Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	8.51	77.18	71.13
Graham Fair Price	2.01	78.23	76.69
PEG	-76.17	4.93	-20.69
Price/Book	14.87	5.75	5.01
Price/Cash Flow	95.34	246.51	126.19
Prices/Earnings	6.50	34.32	32.22
Price/Sales	76.53	27.57	15.62
Price/FCF	95.34	246.51	126.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.46	0.48	0.65
Operating Margin	62.39	0.26	0.16
ROA	6.05	0.02	0.02
ROE	0.04	0.04	7.86
ROIC	0.03	0.03	5.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.13	-99.85
Dividends QOQ	< 0.005	0.09	17579.80
EBIT QOQ	-0.01	0.03	182.47
EPS QOQ	-0.02	0.07	346.96
FCF QOQ	< 0.005	-0.43	16607.49
Revenue QOQ	0.56	-0.36	-35.18
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.96	44.83	4.35
Days Sales Outstanding (DSO)	35.99	58.07	61.33
Inventory Turnover	2.10	2.01	-4.17
Debt/Capitalization	0.34	0.34	1.52
Quick Ratio	0.62	0.70	12.79
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	82.03	80.57	-1.78
Cash	9.63	10.06	4.44
Capex	-2.38	-2.17	8.52
Free Cash Flow	3.25	1.88	-42.24
Revenue	26.30	16.81	-36.08
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.80	0.91	13.40
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.19	5.00	-3.64
Naive Interpretation	Member

06 - Financial Health · Bad

Rating